Ocugen
(NASDAQ:OCGN)
$1.485
-0.025[-1.66%]
Last update: 1:37PM (Delayed 15-Minutes)
Get Real Time Here
Day Range1.48 - 1.5452 Wk Range1.48 - 4.9Open / Close1.5 / -Float / Outstanding161.1M / 218.9M
Vol / Avg.1.4M / 4.8MMkt Cap325MP/E-50d Avg. Price1.72
Div / Yield-Payout Ratio-Total Float161.1MEPS-0.1

Ocugen Stock (NASDAQ:OCGN), Quotes and News Summary

Ocugen Stock (NASDAQ: OCGN) stock price, news, charts, stock research, profile.

Loading...
Day Range1.48 - 1.5452 Wk Range1.48 - 4.9Open / Close1.5 / -Float / Outstanding161.1M / 218.9M
Vol / Avg.1.4M / 4.8MMkt Cap325MP/E-50d Avg. Price1.72
Div / Yield-Payout Ratio-Total Float161.1MEPS-0.1
Henry Khederian - Sep 28, 2022, 9:42AM
Henry Khederian - Sep 19, 2022, 11:11AM
Globe Newswire - Apr 19, 2022, 5:32PM
InvestorsObserver - Nov 10, 2022, 5:54AM
Seeking Alpha - Nov 8, 2022, 10:33AM
InvestorsObserver - Oct 24, 2022, 10:04AM
InvestorPlace - Oct 12, 2022, 10:11AM
InvestorsObserver - Oct 10, 2022, 12:05PM
InvestorsObserver - Sep 29, 2022, 7:23AM
InvestorPlace - Sep 28, 2022, 10:15AM
Seeking Alpha - Sep 28, 2022, 8:13AM
InvestorsObserver - Sep 28, 2022, 6:56AM
InvestorsObserver - Sep 27, 2022, 9:59AM
InvestorsObserver - Sep 20, 2022, 6:57AM
InvestorPlace - Sep 8, 2022, 4:05PM
Sector: Health Care.Industry: Biotechnology
Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug one to many and novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. The company is co-developing Bharat Biotech's COVAXIN vaccine candidate for COVID-19 in the U.S. and Canadian markets.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-24
REV
Q3 2022Est.ActualSurprise
EPS-0.100-0.100 0.0000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Ocugen (OCGN) stock?

A

You can purchase shares of Ocugen (NASDAQ: OCGN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Ocugen's (OCGN) competitors?

Q

What is the target price for Ocugen (OCGN) stock?

A

The latest price target for Ocugen (NASDAQ: OCGN) was reported by Mizuho on Tuesday, August 23, 2022. The analyst firm set a price target for 5.00 expecting OCGN to rise to within 12 months (a possible 236.70% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Ocugen (OCGN)?

A

The stock price for Ocugen (NASDAQ: OCGN) is $1.485 last updated Today at November 28, 2022, 6:37 PM UTC.

Q

Does Ocugen (OCGN) pay a dividend?

A

There are no upcoming dividends for Ocugen.

Q

When is Ocugen (NASDAQ:OCGN) reporting earnings?

A

Ocugen’s Q4 earnings are confirmed for Friday, February 24, 2023.

Q

Is Ocugen (OCGN) going to split?

A

There is no upcoming split for Ocugen.

Q

What sector and industry does Ocugen (OCGN) operate in?

A

Ocugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.